Related Experiment Video
Updated: Jun 21, 2025

Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
Decreasing Blood Transfusions in Premature Infants Through Quality Improvement
Kwai Tei C Chan Poon1, Lusia Li1, Rick Pittman1
1Department of Pediatrics, Division of Neonatology, Duke University Hospital, Durham, North Carolina.
Insights
This study reduced packed red blood cell transfusions (pRBCT) in preterm infants (26-34 weeks gestation) by 46.6%. Quality improvement strategies successfully decreased transfusions without impacting mortality or necrotizing enterocolitis.
Area of Science:
- Neonatal Medicine
- Pediatric Hematology
- Quality Improvement Science
Background:
- Packed red blood cell transfusions (pRBCT) are common in preterm infants and associated with morbidity.
- Preterm infants between 26 and 34 weeks' gestational age may receive preventable pRBCT.
- Reducing pRBCT in this population is a key quality improvement goal.
Purpose of the Study:
- To decrease pRBCT in preterm infants (26-34 weeks gestation) by 20% using quality improvement methods.
- To implement evidence-based transfusion guidelines and supportive therapies.
- To monitor transfusion rates and related process measures.
Main Methods:
- A quality improvement project was conducted in a Neonatal Intensive Care Unit (NICU) from July 2018 to February 2023.
- Interventions included evidence-based transfusion thresholds, erythropoiesis support, and reduced laboratory draw volumes.
- Statistical process control charts monitored pRBCT rates, erythropoietin use, and laboratory panel utilization.
Main Results:
- pRBCT decreased by 46.6%, from 23.8 to 12.7 transfusions per 1000 patient days.
- Erythropoietin use and capillary panel testing increased; basic metabolic panel use decreased.
- No significant changes were observed in mortality or necrotizing enterocolitis rates.
- The observed improvements were sustained for 24 months.
Conclusions:
- A combination of quality improvement strategies can significantly decrease pRBCT in preterm infants (26-34 weeks gestation).
- These interventions are effective and sustainable.
- This approach offers a viable method for reducing transfusion-related risks in this vulnerable population.
Background And Objectives:
Packed red blood cell transfusions (pRBCT) in preterm infants have been associated with significant morbidity. Although infants <26 weeks' gestational age typically require several pRBCT, preterm infants born between 26 and 34 weeks' gestational age may also require pRBCT during their hospitalization that are potentially preventable. We aimed to reduce pRBCT in this population by 20%.
Methods:
This quality improvement project was conducted in the Duke University Hospital NICU between July 2018 and February 2023. Interventions included the implementation of evidence-based transfusion thresholds, supporting bone marrow erythropoiesis, and reducing laboratory specimen volumes by increasing capillary test panels. The rates per 1000 patient days for pRBCT (outcome measure), number of new patients initiated on erythropoietin (process measure), number of basic metabolic panels (process measure), and total capillary panels (process measure) were monitored during the project period. Statistical process control charts were used to observe trends over time.
Results:
Among infants born between 26 0/7 and 34 6/7 weeks' gestational age, the rate of pRBCT decreased from an average of 23.8 to 12.7 transfusions per 1000 patient days, which is a 46.6% decrease. Increases in the use of erythropoietin and capillary panels were observed, along with a decrease in the use of basic metabolic panels. There was no change in mortality or the rate of necrotizing enterocolitis. Improvement was sustained for 24 months after implementation.
Conclusions:
pRBCT can be decreased in preterm infants born between 26 and 34 completed weeks' gestation through a combination of strategies utilizing quality improvement methodology.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Errors occurring during blood pressure monitoring
Several factors...
Rh Blood Group